← Back
$ARQT All transactions

Arcutis Biotherapeutics, Inc.

A

$ Value

$0

Shares

20,568

Price

$0

Filed

Jun 16

Insider

Name

Krishnamohan Neha

Title

CIK

0001866171

Roles

Director

Transaction Details

Transaction Date

2025-06-12

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

20,568

Footnotes

Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 12, 2025, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date. Upon vesting of the RSUs, the settlement has been deferred by the Reporting Person, pursuant to the terms of the RSU Deferral Election Form adopted on November 15, 2024, maintained by the Company. | The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 12, 2025, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date.

Filing Info

Accession No.

0002065881-25-000024

Form Type

4

Issuer CIK

0001787306

Krishnamohan Neha's History

Date Ticker Type Value
2025-11-15 ARTV F $11K
2025-11-13 ARQT M $233K
2025-11-13 ARQT M $92K
2025-11-13 ARQT $911K
2025-11-13 ARQT $29K
2025-11-13 ARQT M $0
2025-11-13 ARQT M $0
2025-08-15 ARTV F $16K
2025-06-12 ARQT A $0
2025-06-12 ARQT A $0

Other Insiders at ARQT (90d)

Insider Bought Sold Last
Leonard Keith R $997K 2026-03-02
Burnett Patrick
See Remarks
$505K 2026-03-02
Matsuda Masaru
See Remarks
$1.3M 2026-03-02
Welgus Howard G. $746K 2026-04-01
Watanabe Todd
See Remarks
$1.4M 2026-03-02
Edwards Larry Todd
See Remarks
$145K 2026-03-02
Vairavan Latha
SVP Chief Financial Officer
$106K 2026-03-02